Loss of NKG2D in murine NK cells leads to increased perforin production upon long‐term stimulation with IL‐2-Reference-Cited by-同舟云学术

Loss of NKG2D in murine NK cells leads to increased perforin production upon long‐term stimulation with IL‐2

Published:2020-02-20 Issue:6 Volume:50 Page:880-890
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Prinz Daniela¹,Klein Klara¹,List Julia¹,Knab Vanessa M.¹,Menzl Ingeborg¹^ORCID,Leidenfrost Nicoletta¹,Heller Gerwin²,Polić Bojan³^ORCID,Putz Eva Maria⁴^ORCID,Witalisz‐Siepracka Agnieszka¹,Sexl Veronika¹,Gotthardt Dagmar¹^ORCID

Affiliation:

1. Institute of Pharmacology and ToxicologyUniversity of Veterinary Medicine Vienna Austria

2. Institute of Internal Medicine IMedical University Vienna Austria

3. Department of Histology and Embryology, Faculty of MedicineUniversity of Rijeka Rijeka Croatia

4. St. Anna Children's Cancer Research Institute (CCRI)Medical University of Vienna Vienna Austria

Funder

Austrian Science Fund

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201948222

Reference42 articles.

1. Functions of natural killer cells

2. Up on the tightrope: natural killer cell activation and inhibition

3. NKG2D Receptor and Its Ligands in Host Defense

4. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages

5. Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant human interleukin-2 corrects NK cell phenotype and functional activity in patients with post-COVID syndrome;Cytokines and inflammation;2024-09-04

2. Systematic Review: JAK-STAT Regulation and Its Impact on Inflammation Response in ARDS from COVID-19;Immuno;2024-05-14

3. Microenvironmental signals shaping NK‐cell reactivity in cancer;European Journal of Immunology;2023-05-28

4. Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome;Pharmaceuticals;2023-04-03

5. Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer;Pharmaceutics;2023-01-17